Cover Image
Market Research Report
Product code
757036

Asia Pacific Opioids Drugs Market Forecast 2019-2028

Published: | Inkwood Research | 120 Pages | Delivery time: 2-3 business days

Price

Back to Top
Asia Pacific Opioids Drugs Market Forecast 2019-2028
Published: May 11, 2020
Inkwood Research
Content info: 120 Pages
Delivery time: 2-3 business days
  • ALL
  • Description
  • Table of Contents
Description

KEY FINDINGS

The Asia Pacific opioids drugs market is estimated to record a CAGR of 3.02% over the forecast period, 2019-2028. The surge in palliative care for patients undergoing intense suffering, is one of the significant factors driving market growth in the region.

MARKET INSIGHTS

The growth rate of the Asia Pacific opioids drugs market is further analyzed by dividing the region into respective countries such as Vietnam, Thailand, Japan, Australia &New Zealand, China, Indonesia, India, South Korea, and the rest of Asia Pacific that includes Singapore, Philippines, among others. In Indonesia, the use of opioids for cancer patients is very low due to the inability to assess pain and dose correctly, and fear of addiction. The country has taken positive steps to avoid opioids overdose and infectious diseases, such as opioid substitution therapy, needle, and syringe programs, and increased access to HIV treatment. Due to COVID-19, Indonesia has restricted the import of opioid drugs. In countries like Thailand, cancer is one of the critical health issues. But there are several issues in cancer pain management. The healthcare society is reluctant to validate opioid analgesics for fear of addiction.

In Vietnam, drug users increased by 16% in 2016, in comparison to 2015. The government implemented a project with a budget of $xx to improve and combine information and mass communication campaigns with community-based activities for the prevention of drug abuse. Australia spent 9.1% of its GDP on healthcare in 2017. There are several organizations that create pain awareness in the country, as one in five Australians live with chronic pain, including children and adolescents. Such awareness programs can help people to understand the usage of opioid medication. In the rest of Asia Pacific countries, there is an urgent need to precisely form policies to increase access to opioid medication that include palliative care.

COMPETITIVE INSIGHTS

Sun Pharmaceuticals Industries Ltd, Johnson & Johnson, Lupin Ltd, Pfizer Inc, Teva Pharmaceutical Industries Ltd, etc. are some of the prominent companies functioning in the market.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 22725

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING ROAD ACCIDENTS AND SURGICAL PROCEDURES
    • 3.2.2. ESCALATING PALLIATIVE CARE FOR PATIENTS SUFFERING INTENSELY
    • 3.2.3. USAGE OF ABUSE DETERRENT FORMULATIONS TO RESTRICT THE OPIOID ABUSE
    • 3.2.4. GROWING OCCURRENCE OF CHRONIC PAIN
  • 3.3. KEY RESTRAINTS
    • 3.3.1. MISUSE OF OPIOIDS
    • 3.3.2. STRINGENT REGULATORY FRAMEWORK

4. KEY ANALYTICS

  • 4.1. KEY INVESTMENT INSIGHTS
  • 4.2. PORTER'S FIVE FORCE ANALYSIS
    • 4.2.1. BUYER POWER
    • 4.2.2. SUPPLIER POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. REGULATORY FRAMEWORK
  • 4.6. TECHNOLOGICAL ADVANCEMENT

5. MARKET BY PRODUCT

  • 5.1. BUPRENORPHINE
  • 5.2. FENTANYL
  • 5.3. HYDROCODONE
  • 5.4. MORPHINE
  • 5.5. OXYCODONE
  • 5.6. TRAMADOL
  • 5.7. OTHER PRODUCTS

6. MARKET BY APPLICATION

  • 6.1. PAIN RELIEF
    • 6.1.1. CANCER PAIN
    • 6.1.2. POSTOPERATIVE PAIN MANAGEMENT
    • 6.1.3. LOW BACK PAIN
    • 6.1.4. ORTHOPEDIC
    • 6.1.5. FIBROMYALGIA
    • 6.1.6. NEUROPATHIC
  • 6.2. ANESTHESIA
  • 6.3. COUGH SUPPRESSION
  • 6.4. DIARRHEA SUPPRESSION
  • 6.5. DEADDICTION

7. GEOGRAPHICAL ANALYSIS

  • 7.1. ASIA PACIFIC
    • 7.1.1. CHINA
    • 7.1.2. JAPAN
    • 7.1.3. INDIA
    • 7.1.4. SOUTH KOREA
    • 7.1.5. INDONESIA
    • 7.1.6. THAILAND
    • 7.1.7. VIETNAM
    • 7.1.8. AUSTRALIA & NEW ZEALAND
    • 7.1.9. REST OF ASIA PACIFIC

8. COMPANY PROFILES

  • 8.1. ACURA PHARMACEUTICALS INC
  • 8.2. ALLERGAN PLC
  • 8.3. BIODELIVERY SCIENCES INTERNATIONAL INC
  • 8.4. CIPHER PHARMACEUTICALS INC
  • 8.5. COLLEGIUM PHARMACEUTICAL INC
  • 8.6. DAIICHI SANKYO INC
  • 8.7. EGALET CORP
  • 8.8. HIKMA PHARMACEUTICALS PLC
  • 8.9. INDIVIOR INC
  • 8.10. JANSSEN PHARMACEUTICALS INC
  • 8.11. JOHNSON & JOHNSON
  • 8.12. LANNETT CO. INC
  • 8.13. LUPIN LTD
  • 8.14. MYLAN NV
  • 8.15. PFIZER INC
  • 8.16. PURDUE PHARMA LP
  • 8.17. SANOFI-AVENTIS S.A
  • 8.18. SUN PHARMACEUTICAL INDUSTRIES LIMITED (SUN PHARMA)
  • 8.19. TEVA PHARMACEUTICAL INDUSTRIES LTD

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - OPIOIDS DRUGS
  • TABLE 2: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: ASIA PACIFIC PAIN RELIEF MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION):
  • TABLE 7: ASIA PACIFIC PAIN RELIEF MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION):

TABLE8: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

  • TABLE 9: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: ASIA PACIFIC OPIOIDS DRUGS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2019
  • FIGURE 6: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY BUPRENORPHINE, 2019-2028 (IN $ MILLION)
  • FIGURE 7: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY FENTANYL, 2019-2028 (IN $ MILLION)
  • FIGURE 8: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY HYDROCODONE, 2019-2028 (IN $ MILLION)
  • FIGURE 9: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY MORPHINE, 2019-2028 (IN $ MILLION)
  • FIGURE 10: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY OXYCODONE, 2019-2028 (IN $ MILLION)
  • FIGURE 11: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY TRAMADOL, 2019-2028 (IN $ MILLION)
  • FIGURE 12: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY OTHER PRODUCTS, 2019-2028 (IN $ MILLION)
  • FIGURE 13: ASIA PACIFIC OPIOIDS DRUGS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019
  • FIGURE 14: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY PAIN RELIEF, 2019-2028 (IN $ MILLION)
  • FIGURE 15: ASIA PACIFIC PAIN RELIEF MARKET, BY CANCER PAIN, 2019-2028 (IN $ MILLION)
  • FIGURE 16: ASIA PACIFIC PAIN RELIEF MARKET, BY POSTOPERATIVE PAIN MANAGEMENT, 2019-2028 (IN $ MILLION)
  • FIGURE 17: ASIA PACIFIC PAIN RELIEF MARKET, BY LOW BACK PAIN, 2019-2028 (IN $ MILLION)
  • FIGURE 18: ASIA PACIFIC PAIN RELIEF MARKET, BY ORTHOPEDIC, 2019-2028 (IN $ MILLION)
  • FIGURE 19: ASIA PACIFIC PAIN RELIEF MARKET, BY FIBROMYALGIA, 2019-2028 (IN $ MILLION)
  • FIGURE 20: ASIA PACIFIC PAIN RELIEF MARKET, BY NEUROPATHIC, 2019-2028 (IN $ MILLION)
  • FIGURE 21: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY ANESTHESIA, 2019-2028 (IN $ MILLION)
  • FIGURE 22: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUGH SUPPRESSION, 2019-2028 (IN $ MILLION)
  • FIGURE 23: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY DIARRHEA SUPPRESSION, 2019-2028 (IN $ MILLION)
  • FIGURE 24: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY DEADDICTION, 2019-2028 (IN $ MILLION)
  • FIGURE 25: ASIA PACIFIC OPIOIDS DRUGS MARKET, COUNTRY OUTLOOK, 2018 & 2028 (IN %)
  • FIGURE 26: CHINA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 27: JAPAN OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 28: INDIA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 29: SOUTH KOREA OPIOIDS DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 30: INDONESIA OPIOID DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 31: THAILAND OPIOID DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 32: VIETNAM OPIOID DRUGS MARKET, 2020-2028 (IN $ MILLION)
  • FIGURE 33: AUSTRALIA & NEW ZEALAND OPIOID DRUGS MARKET, 2020-2028 (IN $ MILLION)